Pepsi Earnings vs. ...
Health Care: Drugs
K-V Pharmaceutical Company (KV.A: NYSE)
$1.62 -0.99 | -37.93%
02/10/12 - 04:05 PM ET
5.06M / 888.80K
Vol / Avg. Vol:2.50 / 2.61
Open / Prev. Close:1.50 - 2.50
Today's Range:0.79 - 13.55
52 Wk Range:92.14%
Performance YTD:TheStreet Rating:
Portfolios with KV.A
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Most Shorted Stocks in B...
- ProBirmiwal Oasis (BIRMX)
- Userjaspy15 Portfolio 1
- UserMG-Speculation
- Userdabower774
Latest KV.A Headlines from TheStreet
- K-V Stock Falls On Unusually High Volume (KV.A) 02.10.12 | 03:02 pm
- The 5 Dumbest Things on Wall Street: First Quarter 04.01.11 | 06:04 am
- K-V Stock Falls On Unusually High Volume (KV.A) 03.30.11 | 11:03 am
- Dumbest of This Week's 5 Dumbest: KV Pharmaceutical Goes Price Hiking 03.19.11 | 09:03 am
- The 5 Dumbest Things on Wall Street: March 18 03.18.11 | 06:03 am
- Tricks of the Trade for 150% Returns 03.17.11 | 10:03 am
- K-V Stock Falls On Unusually High Volume (KV.A) 02.22.11 | 04:02 pm
- Strategic Diagnostics: Small-Cap Winner 01.12.11 | 12:01 pm
- TSC Ratings' Updates: KV Pharmaceutical 09.29.08 | 05:09 pm
- AstraZeneca Loses U.S. Patent Case 01.18.06 | 09:01 am
Press Releases for KV.A
- K-V Pharmaceutical Company Comments On Recent Settlement With The Department Of Justice - PR Newswire 12.07.11 | 09:12 am
- K-V Pharmaceutical Comments On ACOG And SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena⢠And Compounded 17P - PR Newswire 10.13.11 | 10:10 am
- K-V Pharmaceutical Company To Present At Imperial Capital's 5th Annual Global Opportunities Conference - PR Newswire 09.28.11 | 04:09 pm
- K-V Pharmaceutical Company Announces Filing Of First Quarter Fiscal 2012 Form 10-Q And Schedules Investor Conference Call - PR Newswire 08.09.11 | 08:08 am
- K-V Pharmaceutical Company Announces The Completion Of The Sale Of Nesher Pharmaceuticals, Inc. Its Generic Pharmaceutical Business - PR Newswire 08.08.11 | 06:08 pm
Partner Headlines for KV.A
- KV Pharmaceuticals Facing Difficulty Overcoming Negative Sentiment Even With A New FDA Investigation - Seeking Alpha 11.17.11 | 08:11 am
- UPDATE: K-V Pharmaceutical Announces Independent Laboratory Testing Demonstrates Important Quality Differences Between FDA-Approved Makena and Compounded 17P Formulations - Benzinga 11.08.11 | 04:11 pm
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Beach Point Capital's Favorite Stock Picks - Seeking Alpha 06.22.11 | 09:06 am
- KV Pharmaceutical Overvalued? - Seeking Alpha 02.08.11 | 08:02 am
- Russell 2000's Most Attractive Stocks - SeekingAlpha.com 04.26.10 | 12:04 pm
- Drug Pipeline Pulse Check: Teva on a Tear - SeekingAlpha.com 04.06.10 | 03:04 pm
